Gene Biotherapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Gene Biotherapeutics's balance sheet done over the years? Its assets were worth $0 last year. null of Gene Biotherapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $0.
Debt to Assets
| 2013 | 2786377 | 1.60M | 57.47% |
|---|---|---|---|
| 2014 | 746093 | 2.42M | 325.43% |
| 2015 | 37303 | 3.83M | 10271.67% |
| 2016 | 1110817 | 4.40M | 396.15% |
| 2017 | 209773 | 5.36M | 2557.97% |
| 2018 | 161895 | 5.79M | 3576.88% |
| 2019 | 35435 | 4.88M | 13786.36% |
| 2020 | 566982 | 5.13M | 905.71% |
| 2021 | 0 | 0 | |
| 2022 | 0 | 0 |
CRXM Balance Sheet (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 0 | 0 | 386.02K | 400 | 82.11K | 48.98K | 930.39K | 21.54K | 216.73K | 22.48K |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 159.83K |
Other current assets | 0 | 0 | 24.61K | 16.76K | 18.96K | 25K | 10.42K | 18.46K | 405.91K | 309.2K |
Total current assets | 0 | 0 | 410.63K | 32.79K | 101.08K | 73.98K | 940.82K | 30.77K | 419.69K | 491.52K |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 0 | 0 | 149.27K | 2.64K | 60.81K | 124.01K | 158.22K | 6.52K | 16.41K | 30.19K |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 300K | 1.69M |
Other non-current assets | 0 | 0 | 7.07K | 7 | 0 | 11.76K | 11.76K | 0 | 9.98K | 564.98K |
Total non-current assets | 0 | 0 | 156.34K | 2.64K | 60.81K | 135.78K | 169.99K | 6.52K | 326.40K | 2.29M |
Total assets | 0 | 0 | 566.98K | 35.43K | 161.89K | 209.77K | 1.11M | 37.30K | 746.09K | 2.78M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 0 | 0 | 9.61K | 0 | -946.14K | -688.43K | 0 |
Short term debt | 0 | 0 | 1.15M | 999.17K | 1.06M | 1.91M | 1.05M | 946.14K | 0 | 0 |
Total current liabilities | 0 | 0 | 5.02M | 4.76M | 5.79M | 5.35M | 4.39M | 3.83M | 2.42M | 1.60M |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | 0 | 107.89K | 122.20K | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 0 | 3 | -1 | 2.92M | 10.26K | 6.88K | 0 | 0 | 990.27K |
Total non-current liabilities | 0 | 0 | 107.89K | 122.20K | 2.92M | 10.26K | 6.88K | 1.79M | 1.20M | 990.27K |
Total liabilities | 0 | 0 | 5.13M | 4.88M | 5.79M | 5.36M | 4.40M | 3.83M | 2.42M | 1.60M |
| Data source | Data source | Data source | Data source | Data source | Data source |